Marshall Wace’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$854K Buy
1,080,667
+272,871
+34% +$194K ﹤0.01% 2283
2026
Q1
$372K Sell
807,796
-5,118,949
-86% -$4.72M ﹤0.01% 2585
2025
Q4
$13M Buy
5,926,745
+4,156,969
+235% +$6.69M 0.01% 775
2025
Q3
$2.81M Buy
+1,769,776
New +$2.3M ﹤0.01% 1451

Other funds holding GUTS

Marshall Wace's GUTS Position: Q2 2026 in Review

Marshall Wace increased its Fractyl Health (GUTS) stake by 34% in Q2 2026, buying an estimated $194K and bringing the position to 1,080,667 shares worth $854K. The position accounts for ﹤0.01% of the portfolio, ranked #2283.

Marshall Wace first reported a position in GUTS in Q3 2025 and has held it in 4 quarters since. The position peaked at $13M in Q4 2025. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • Marshall Wace held 1,080,667 shares of Fractyl Health worth $854K as of Q2 2026.
  • Marshall Wace bought 272,871 Fractyl Health shares in Q2 2026, an estimated $194K.
  • Fractyl Health made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2283 holding.
  • Marshall Wace first reported a position in Fractyl Health in Q3 2025 and has held it in 4 quarters since.
  • Marshall Wace's Fractyl Health position peaked at $13M in Q4 2025.
  • 77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.